More recently, there was a study showed that potent and selective UCHL1 inhibitors can down-regulate the fibrotic responses in a cellular model of IPF, which indicated that UCHL1 may be a potential target to cure IPF (Panyain et al., 2020). This evidence concerns the gene UCHL1 and idiopathic pulmonary fibrosis.